EX-99.3 4 d393451dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

Q2 2022 - Key Financial and Business Highlights

 

   

Record quarterly revenues of $22.5 million, up 28.4% from Q2 2021 and up 4.0% from Q1 2022

 

   

Q2 2022 GAAP gross margin was 70.2% compared to 71.2% in Q2 2021 (non-GAAP gross margin was 71.0% compared to 71.1% in Q2 2021)

 

   

Q2 2022 GAAP Net Loss was $(10.0) million, which included net financial expenses of $3.6 million, primarily from devaluation of Israeli-shekel related cash balance, compared to Net Loss of $(3.7) million in Q2 2021, and Adjusted EBITDA loss in the second quarter was $(4.5) million, compared to $(2.1) million in Q2 2021

 

   

Strong balance sheet with working capital of $168.3 million, and $156.8 million in cash, cash equivalents and short-term deposits as of June 30, 2022

 

   

Automotive:

 

   

Continue to make progress with the evaluation of the company’s MIPI A-PHY new VA7000 chipsets, as over 30 OEMs, Tier 1s and Tier 2s are evaluating this product for ADAS and surround view applications

 

   

Audio-video:

 

   

Received substantial demand for VS3000, Valens Semiconductor’s newest audio-video product family, from Tier 1 customers across many geographies

 

   

Crestron Electronics announced full suite of more than 24 Professional Audio-Video (ProAV) products powered by the VS3000 for use by enterprises, in education and more. This adds to the multiple VS3000-based products already introduced by Crestron

 

   

Interest in the company’s technology in the medical space continues to grow. Introduced a connectivity solution with Würth Elektronik for medical imaging in unprecedented resolution that complies with the strict medical isolation specifications

 

1


VALENS SEMICONDUCTOR LTD.

SUMMARY OF FINANCIAL RESULTS

(U.S. Dollars in thousands, except per share amounts)

(Unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2022     2021     2022     2021  

Revenues

     22,481       17,510       44,101       30,874  

Gross Profit

     15,784       12,467       31,224       21,999  

Gross Margin

     70.2     71.2     70.8     71.3

Net loss

     (9,995     (3,698     (15,045     (10,074

Working Capital1

     168,283       56,133       168,283       56,133  

Cash, cash equivalents and short-term deposits2

     156,754       51,873       156,754       51,873  

Net cash used in operating activities

     (4,251     (6,443     (12,654     (9,651

Non-GAAP Financial Data

        

Non-GAAP Gross Margin3

     71.0     71.1     71.5     71.4

Adjusted EBITDA4

     (4,469     (2,116     (8,555     (6,419

Non-GAAP Loss per share5 (in U.S. Dollars)

   $ (0.08   $ (0.16   $ (0.13   $ (0.57

 

1

Working Capital is calculated as Total Current Assets, less Total Current Liabilities, as of the last day of the period.

2

As of the last day of the period.

3

GAAP Gross Profit excluding share-based compensation and depreciation expenses, divided by revenue. For the three months ended June 30, 2022, and 2021, share-based compensation and depreciation expenses were $181 thousand and $(10) thousand respectively. For the six months ended June 30, 2022, and 2021, share-based compensation and depreciation expenses were $321 thousand and $47 thousand respectively.

4

Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation and change in fair value of Forfeiture Shares, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity. Please refer to the appendix at the end of this report for a reconciliation to the most directly comparable measure in accordance with GAAP.

5

See reconciliation of GAAP to non-GAAP financial measures.

 

2


VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. Dollars in thousands, except share and per share amounts)

(Unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2022     2021     2022     2021  

REVENUES

     22,481       17,510       44,101       30,874  

COST OF REVENUES

     (6,697     (5,043     (12,877     (8,875
  

 

 

   

 

 

   

 

 

   

 

 

 

GROSS PROFIT

     15,784       12,467       31,224       21,999  

OPERATING EXPENSES:

        

Research and development expenses

     (14,904     (10,956     (29,031     (21,354

Sales and marketing expenses

     (4,473     (3,222     (8,682     (6,332

General and administrative expenses

     (4,340     (2,366     (8,641     (4,544
  

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL OPERATING EXPENSES

     (23,717     (16,544     (46,354     (32,230
  

 

 

   

 

 

   

 

 

   

 

 

 

OPERATING LOSS

     (7,933     (4,077     (15,130     (10,231

Change in fair value of Forfeiture Shares

     1,538       —         4,142       —    

Financial income (expenses), net

     (3,560     503       (3,675     336  
  

 

 

   

 

 

   

 

 

   

 

 

 

LOSS BEFORE INCOME TAXES

     (9,955     (3,574     (14,663     (9,895

INCOME TAXES

     (43     (124     (389     (179

LOSS AFTER INCOME TAXES

     (9,998     (3,698     (15,052     (10,074

Equity in earnings of investee

     3       —         7       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

NET LOSS

     (9,995     (3,698     (15,045     (10,074

EARNINGS PER SHARE DATA:

        

BASIC AND DILUTED NET LOSS PER ORDINARY SHARE6

(in U.S. Dollars)

   $ (0.10   $ (0.68   $ (0.15   $ (1.61

WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF NET LOSS PER ORDINARY

     97,442,359       11,020,299       97,296,206       10,927,357  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

6

See note 5.

 

3


VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(U.S. Dollars in thousands)

(Unaudited)

 

     June 30,
2022
     December 31,
2021
 

ASSETS

     

CURRENT ASSETS

     

Cash and cash equivalents

     46,577        56,791  

Short-term deposits

     110,177        117,568  

Trade accounts receivable

     10,047        7,095  

Inventories

     17,318        9,322  

Prepaid expenses and other current assets

     4,492        8,255  
  

 

 

    

 

 

 

TOTAL CURRENT ASSETS

     188,611        199,031  

LONG-TERM ASSETS:

     

Property and equipment, net

     2,571        2,741  

Operating lease Right-Of-Use (ROU) assets7

     4,408        —    

Other assets

     638        828  
  

 

 

    

 

 

 

TOTAL LONG-TERM ASSETS

     7,617        3,569  
  

 

 

    

 

 

 

TOTAL ASSETS

     196,228        202,600  
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

CURRENT LIABILITIES8

     20,328        15,699  

LONG-TERM LIABILITIES:

     

Forfeiture shares

     516        4,658  

Non-current operating leases liabilities9

     2,126        —    

Other long-term liabilities

     48        46  
  

 

 

    

 

 

 

TOTAL LONG-TERM LIABILITIES

     2,690        4,704  

TOTAL LIABILITIES

     23,018        20,403  

SHAREHOLDERS’ EQUITY

     173,210        182,197  
  

 

 

    

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

     196,228        202,600  
  

 

 

    

 

 

 

 

7

As of January 1, 2022, the company has implemented the FASB ASU No. 2016-02, Leases (ASC 842), on the recognition, measurement, presentation, and disclosure of leases.

8

As of June 30, 2022, includes $1,814 thousand of current maturities of operating leases liabilities (none as of December 31, 2021); see footnote 7.

9

See footnote 7.

 

4


VALENS SEMICONDUCTOR LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. Dollars in thousands)

(Unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2022     2021     2022     2021  

CASH FLOW FROM OPERATING ACTIVITIES

        

Net loss for the period

     (9,995     (3,698     (15,045     (10,074

Adjustments to reconcile net loss to net cash used in operating activities:

        

Income and expense items not involving cash flows:

        

Depreciation

     347       266       667       522  

Stock-based compensation

     3,117       1,695       5,908       3,290  

Exchange rate differences

     4,501       (545     4,972       (231

Interest from short-term deposits

     (132     37       (295     219  

Change in fair value of forfeiture shares

     (1,538     —         (4,142     —    

Reduction in the carrying amount of ROU assets

     424       —         844       —    

Changes in operating assets and liabilities:

        

Trade accounts receivable

     166       (2,475     (2,952     767  

Prepaid expenses and other current assets

     3,245       (458     3,763       (1,588

Inventories

     (4,852     (1,752     (7,996     (2,541

Other assets

     86       (26     190       (31

Current Liabilities

     1,189       513       2,742       23  

Change in operating lease liabilities

     (811     —         (1,312     —    

Other long-term liabilities

     2       —         2       (7

Net cash used in operating activities

     (4,251     (6,443     (12,654     (9,651

CASH FLOWS FROM INVESTING ACTIVITIES:

        

Investment in short-term deposits

     (13,088     (4,520     (31,340     (4,520

Maturities of short-term deposits

     21,900       12,500       37,400       29,500  

Purchase of property and equipment

     (244     (127     (424     (505
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by investing activities

     8,568       7,853       5,636       24,475  

CASH FLOWS FROM FINANCING ACTIVITIES:

        

Deferred issuance costs

     —         (218     —         (218

Exercise of options

     96       589       150       665  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     96       371       150       447  

Effect of exchange rate changes on cash and cash equivalents

     (2,830     531       (3,346     217  

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     1,583       2,312       (10,214     15,488  

CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD

     44,994       39,492       56,791       26,316  
  

 

 

   

 

 

   

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD

     46,577       41,804       46,577       41,804  

SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION

        

Cash paid for taxes

     65       147       121       224  

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

        

Trade accounts payable on account of property and equipment

     —         —         73       —    

Unpaid issuance costs

     —         2,722       —         2,722  

Operating lease liabilities arising from obtaining operating right-of-use assets

     104       —         350       —    

 

5


VALENS SEMICONDUCTOR LTD.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(U.S. Dollars in thousands)

(Unaudited)

The following table provides a reconciliation of Net loss to Adjusted EBITDA, a non-GAAP measure. Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation and change in fair value of Forfeiture Shares, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity.

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2022     2021     2022     2021  

Net loss

     (9,995     (3,698     (15,045     (10,074

Adjusted to exclude the following:

        

Change in fair value of Forfeiture Shares

     (1,538     —         (4,142     —    

Financial expense (income), net

     3,560       (503     3,675       (336

Income taxes

     43       124       389       179  

Equity in earnings of investee

     (3     —         (7     —    

Depreciation

     347       266       667       522  

Stock-based compensation expenses

     3,117       1,695       5,908       3,290  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

     (4,469     (2,116     (8,555     (6,419

 

6


VALENS SEMICONDUCTOR LTD.

RECONCILIATION OF GAAP TO NON-GAAP Tables

(U.S. Dollars in thousands)

(Unaudited)

The following tables provide a calculation of the GAAP Loss per share and reconciliation to Non-GAAP Loss per share.

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 

GAAP Loss per Share

   2022     2021     2022     2021  

GAAP Net Loss

     (9,995     (3,698     (15,045     (10,074

Adjusted to include the following:

        

Accrued dividend related to Preferred Shares

     —         (3,788     —         (7,478
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Loss used for computing Loss per Share

     (9,995     (7,486     (15,045     (17,552

Earnings Per Share Data:

        

GAAP Loss per Share (in U.S. Dollars)

   $ (0.10   $ (0.68   $ (0.15   $ (1.61

Weighted average number of shares used in
calculation of net loss per share

     97,442,359       11,020,299       97,296,206       10,927,357  
     Three Months Ended
June 30,
    Six Months Ended
June 30,
 

Non-GAAP Loss per Share10

   2022     2021     2022     2021  

GAAP Net loss

     (9,995     (3,698     (15,045     (10,074

Adjusted to exclude the following:

        

Stock based compensation

     3,117       1,695       5,908       3,290  

Depreciation

     347       266       667       522  

Change in fair value of Forfeiture Shares

     (1,538     —         (4,142     —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Loss used for computing Loss per Share

     (8,069     (1,737     (12,612     (6,262

Earnings Per Share Data:

        

Non-GAAP Loss per Share (in U.S. Dollars)

   $ (0.08   $ (0.16   $ (0.13   $ (0.57

Weighted average number of shares used in calculation of net loss per share

     97,442,359       11,020,299       97,296,206       10,927,357  

 

10

The company calculates its non-GAAP Loss per Share as GAAP Net Loss adjusted to exclude the following: Stock based compensation, depreciation, and the change in fair value of Forfeiture Share (the change in fair value of Forfeiture Shares totaled at $1,538 thousand and $2,604 thousand for the second and first quarters of 2022, respectively) divided by the weighted average number of shares used in calculation of net loss per share.

 

7